プログラム委員会
-
E. Stewart Geary, MD Senior Vice President
Eisai Co., Ltd., Japan -
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan -
Katsuhiko Ichimaru Review Director, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Kazuhiko Ishida, MSc, RPh Director, Pharmacovigilance
Astellas Pharma Inc., Japan -
Tomoyuki Kakizume, PhD Statistical & Quantitative Sciences
Takeda Pharmaceutical Co. Ltd.,, Japan -
Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
Pfizer R&D Japan G.K., Japan -
Yukihiro Matsuda, MSc Director, Clinical Delivery
ICON Clinical Research GK, Japan -
Yukiko Nishimura, PhD, MSc President
NPO ASrid, Japan -
Mika Ogasawara Data Quality Lead, Biometrics and Data Management
Pfizer R&D Japan G.K., Japan -
Takashi Sato, MSc, PMP
PM Orchestra Takashi Sato, Japan -
Katsuhiko Sawada, MPharm Director, Research and Development Dept.
Otsuka Medical Devices Co.Ltd., Japan -
Kazuyuki Suzuki, MSc Senior Lead strategy & Execution Patient Engagement group Cuntry Comms & Patient
Novartis Pharma K.K., Japan -
Keiko Tsumori, MSc Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
MSD K.K., Japan -
Nariaki Uemura Development Project Management, Development
Astellas Pharma Inc., Japan -
Tadashi Urashima, PhD Performance and Digital Analytics Lead, Medical & Development Excellence Japan
GlaxoSmithKline K.K., Japan -
Koichiro Yuji, MD, PhD, FACP Project Associate Professor, The Institute of Medical Science
Japan -
Keiichi Inaizumi, MSc Clinical Project Management Group/ Japan Clinical Project Manager
Pfizer R&D Japan, Japan -
Junichi Nishino, MSc, RPh Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan -
Hironobu Saito, PhD Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan -
Junko Sato, PhD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Atsushi Tsukamoto, PhD, MSc Corporate Officer, Head is Therapeutic Area Strategies
Daiichi Sankyo, United States